NEW YORK (GenomeWeb News) – The Bill and Melinda Gates Foundation has given Duke University a two-year, $3 million grant to identify genetic variants responsible for making some people with hemophilia immune to HIV infection.
 
The Center for Human Genome Variation at Duke’s Institute for Genome Sciences and Policy will use the funding to resequence the genomes of 50 individuals with hemophilia in order to discover variants that are most likely to be associated with HIV resistance, Duke University said earlier this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.

Sep
27
Sponsored by
Philips Genomics

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep
28
Sponsored by
Fabric Genomics

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.